E.08 Integrated Safety and Efficacy of Azetukalner: Clinical Evidence Supporting Regulatory Submission as a Next-Generation Antiseizure Medication for Focal Seizures

Monday, December 7, 2026 at 8:30 AM to 10:45 AM · 2 hr. 15 min. (America/Denver)
Platform

Information

Session ID
PLATE26
Presentation Id
3530657
Event ID
24056
Session Type
Presentation